Tinavi Medical Financials
| 688277 Stock | 10.66 0.08 0.74% |
Operating Margin (0.95) | Profit Margin (0.95) | Return On Equity (0.13) |
Tinavi | Select Account or Indicator |
Understanding current and past Tinavi Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Tinavi Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Tinavi Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Tinavi Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tinavi Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Tinavi Medical's management manipulating its earnings.
Tinavi Medical Stock Summary
Tinavi Medical competes with Dymatic Chemicals, Shenzhen Noposion, Suzhou Weizhixiang, Eastroc Beverage, and China World. Tinavi Medical is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100004256 |
| Business Address | Building 7, Beijing, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.tinavi.com |
| Phone | 86 10 8215 6660 |
You should never invest in Tinavi Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Tinavi Stock, because this is throwing your money away. Analyzing the key information contained in Tinavi Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Tinavi Medical Key Financial Ratios
Tinavi Medical's financial ratios allow both analysts and investors to convert raw data from Tinavi Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Tinavi Medical over time and compare it to other companies across industries.| Revenue | 210.04 M | ||||
| Gross Profit | 154.06 M | ||||
| EBITDA | (169.67 M) | ||||
| Net Income | (156.39 M) | ||||
| Total Asset | 1.62 B |
Tinavi Medical Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 713.6M | 1.1B | 1.3B | 1.4B | 1.6B | 1.2B | |
| Other Current Liab | 50.0M | 47.1M | 43.2M | 1.2M | 526.7K | 500.4K | |
| Other Liab | 7.9M | 20.9M | 12.2M | 50.1M | 57.6M | 60.5M | |
| Net Tangible Assets | 582.6M | 989.8M | 999.3M | 918.2M | 1.1B | 769.4M | |
| Retained Earnings | (69.1M) | (117.2M) | (192.1M) | (310.8M) | (467.2M) | (443.9M) | |
| Accounts Payable | 4.2M | 4.0M | 9.6M | 28.5M | 44.1M | 46.3M | |
| Cash | 152.6M | 468.4M | 287.1M | 211.4M | 310.9M | 250.2M | |
| Other Assets | 23.4M | 36.0M | 153.4M | 386.5M | 444.4M | 466.6M | |
| Net Receivables | 53.7M | 15.9M | 27.3M | 28.7M | 46.6M | 28.2M | |
| Inventory | 32.1M | 34.8M | 37.9M | 43.8M | 26.2M | 34.1M | |
| Other Current Assets | 16.5M | 12.9M | 11.0M | 20.8M | 32.7M | 34.4M | |
| Total Liab | 117.3M | 92.7M | 211.5M | 289.4M | 382.0M | 259.0M | |
| Net Invested Capital | 585.3M | 996.0M | 1.0B | 1.1B | 1.5B | 923.3M | |
| Total Current Assets | 527.6M | 794.3M | 507.4M | 373.4M | 488.8M | 435.5M | |
| Net Working Capital | 431.3M | 713.8M | 394.2M | 215.0M | 321.8M | 419.1M | |
| Intangible Assets | 2.7M | 6.3M | 7.6M | 6.7M | 17.2M | 18.1M | |
| Common Stock | 188.3M | 376.5M | 418.4M | 419.8M | 482.8M | 343.5M |
Tinavi Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | (8.7M) | (14.2M) | (22.0M) | (31.8M) | 10.6M | 11.1M | |
| Net Interest Income | 387.9K | 1.6M | 2.4M | (2.6M) | (3.7M) | (3.5M) | |
| Interest Income | 459.5K | 1.6M | 5.8M | 1.4M | 2.8M | 2.1M | |
| Interest Expense | 387.9K | 1.6M | 3.3M | 3.9M | 6.4M | 6.7M | |
| Total Revenue | 229.6M | 135.9M | 156.0M | 156.2M | 210.0M | 170.9M | |
| Gross Profit | 195.0M | 104.6M | 106.1M | 102.6M | 149.4M | 126.3M | |
| Operating Income | (44.8M) | (71.2M) | (103.5M) | (146.4M) | (197.8M) | (187.9M) | |
| Ebit | (66.7M) | (100.6M) | (140.9M) | (148.5M) | (133.7M) | (140.4M) | |
| Research Development | 77.0M | 74.1M | 109.8M | 122.6M | 140.3M | 92.3M | |
| Ebitda | (37.0M) | (62.6M) | (66.0M) | (95.7M) | (86.1M) | (81.8M) | |
| Cost Of Revenue | 34.6M | 31.3M | 50.0M | 53.6M | 60.6M | 44.7M | |
| Income Before Tax | (42.8M) | (68.4M) | (104.7M) | (144.2M) | (150.7M) | (143.2M) | |
| Net Income | (31.0M) | (54.5M) | (79.9M) | (110.6M) | (156.4M) | (148.6M) | |
| Income Tax Expense | (8.7M) | (14.2M) | (22.0M) | (34.4M) | (31.0M) | (29.5M) | |
| Minority Interest | 11.0M | 30.5M | 2.7M | 1.8M | 4.9M | 8.2M |
Tinavi Medical Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Tinavi Medical Techn. It measures of how well Tinavi is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Tinavi Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Tinavi had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Tinavi Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | (134.7M) | 25.7M | 127.7M | 9.6M | (258.2M) | (245.3M) | |
| Change In Cash | (129.0M) | 315.8M | (181.3M) | (75.9M) | 99.5M | 104.4M | |
| Free Cash Flow | 359.7K | (189.7M) | (316.4M) | (147.1M) | (391.5M) | (371.9M) | |
| Depreciation | 7.7M | 8.3M | 33.4M | 44.5M | 40.6M | 22.3M | |
| Other Non Cash Items | 7.5M | 8.6M | 9.6M | 9.6M | 10.5M | 7.6M | |
| Capital Expenditures | 20.2M | 132.2M | 238.7M | 59.6M | 221.0M | 110.8M | |
| Net Income | (31.0M) | (54.5M) | (79.9M) | (110.6M) | (156.4M) | (148.6M) | |
| End Period Cash Flow | 152.6M | 468.4M | 287.1M | 211.2M | 310.6M | 250.2M | |
| Change To Netincome | 8.3M | (8.1M) | (4.5M) | 3.3M | 3.8M | 3.9M |
Tinavi Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tinavi Medical's current stock value. Our valuation model uses many indicators to compare Tinavi Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tinavi Medical competition to find correlations between indicators driving Tinavi Medical's intrinsic value. More Info.Tinavi Medical Technologies is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Tinavi Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tinavi Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Tinavi Medical Techn Systematic Risk
Tinavi Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tinavi Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Tinavi Medical Techn correlated with the market. If Beta is less than 0 Tinavi Medical generally moves in the opposite direction as compared to the market. If Tinavi Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tinavi Medical Techn is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tinavi Medical is generally in the same direction as the market. If Beta > 1 Tinavi Medical moves generally in the same direction as, but more than the movement of the benchmark.
Tinavi Medical Technologies Total Assets Over Time
Tinavi Medical Thematic Clasifications
Tinavi Medical Technologies is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Tinavi Medical December 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tinavi Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tinavi Medical Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tinavi Medical Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Tinavi Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tinavi Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.78 | |||
| Information Ratio | 0.1763 | |||
| Maximum Drawdown | 27.03 | |||
| Value At Risk | (5.85) | |||
| Potential Upside | 8.28 |
Complementary Tools for Tinavi Stock analysis
When running Tinavi Medical's price analysis, check to measure Tinavi Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tinavi Medical is operating at the current time. Most of Tinavi Medical's value examination focuses on studying past and present price action to predict the probability of Tinavi Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tinavi Medical's price. Additionally, you may evaluate how the addition of Tinavi Medical to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets |